Skip to content
Open access

Vaccination rate and vaccine hesitancy of pregnant women, comparison of causes with epidemiological factors during SARS-CoV-2 pandemic

Bilge Doğan Taymur G�ldeniz Toklucu
Jul 2026 · Journal of Health Sciences and Medicine · Vol 9, pp. 928-932 · 0 citations · 14 references

TL;DR

Evaluating SARS-CoV-2 vaccine acceptance and factors related to vaccine hesitancy among pregnant women to identify factors related to vaccine hesitancy among pregnant women found no statistically significant differences.

Abstract

Aims: Vaccine hesitancy remains a major challenge in public health, particularly among pregnant women, who represent a high-risk group for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to evaluate SARS-CoV-2 vaccine acceptance and to identify factors related to vaccine hesitancy among pregnant women. This hospital-based, cross-sectional study was conducted among pregnant women attending routine antenatal care clinics at a tertiary healthcare center.Methods: Pregnant women who voluntarily consented to participate were included in the study. Data were collected using a structured questionnaire covering sociodemographic characteristics, obstetric history, presence of chronic disease, history of SARS-CoV-2 infection, vaccination status, and reasons for vaccine hesitancy. During pregnancy, vaccinated and unvaccinated groups were compared using appropriate statistical techniques.Results: A total of 249 pregnant women were included. The overall acceptance rate of the SARS-CoV-2 vaccine was 47.4%. No statistically significant differences were observed between vaccinated and unvaccinated women in terms of age, education level, employment status, income level, obstetric characteristics, presence of chronic disease, or history of SARS-CoV-2 infection (p>0.05). Gestational age was significantly higher among unvaccinated women compared with vaccinated women (p

Read PDF

Similar papers

Open access Sep 2026

COVID-19 vaccine compliance among pregnant women in Poland during the pandemic

The findings suggest that tailored, evidence-based vaccine communication during antenatal care is particularly relevant for women with lower educational attainment, as well as a significant demographic divide.

Katarzyna Hinca, J. Jassem-Bobowicz, Iwona Jańczewska et al. · 0 citations
Open access Jan 2026

Vaccination Status in Pregnancy: A Cross‐Sectional Study of Two Greek Maternity Hospitals

Purpose This study is aimed at evaluating postpartum women′s vaccination status in two major maternity hospitals in Athens, Greece, and identifying demographic, socioeconomic, and behavioral factors influencing vaccine acceptance. Methods A cross‐sectional study was conducted at Leto General Hospital and Alexandra Hosp...

A. Psarris, Dimitris Baroutis, R. Mantzioros et al. · 0 citations
Aug 2026

A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.

Maternal influenza, pertussis, and COVID-19 vaccination were not associated with increased risks of hypertensive disorders, chorioamnionitis, premature rupture of membranes, antepartum or postpartum haemorrhage, small-for-gestational-age, or low birthweight, and neonatal outcomes were favourable.

Hassen Mohammed, P. Andraweera, Helen Marshall · 0 citations
Open access Sep 2026

Hepatitis E vaccination in women of childbearing age: safety and tolerability outcomes

Hepatitis E virus is a major cause of acute viral hepatitis and is endemic in Pakistan, where it contributes substantially to morbidity and mortality among women of childbearing age. The Hecolin vaccine is a potentially useful preventive measure, but data on its safety in this population remain limited. This study asse...

Nazish Butt, Omar Idris, Bushra Shahid et al. · 0 citations
Open access Sep 2026

Readiness of pregnant women for pertussis vaccination

Willingness to vaccinate during pregnancy was associated with prior regular vaccination, physician recommendation, previous vaccination during pregnancy, and understanding of the purpose of immunization.

E. Krieger, O. Samodova, T. R. Nizovtseva et al. · 0 citations
Review Open access Sep 2026

Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.

COVID-19 vaccination in pregnancy, with or without influenza vaccine coadministration, was safe and well-tolerated by survey respondents and no new or worsening health problems were reported after coadministration of COVID-19 and influenza vaccines during pregnancy.

Sophie Tran, E. McClymont, S. Blitz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.